| scholarly article | Q13442814 |
| P50 | author | Christof Seidl | Q114400028 |
| Oliver Schilling | Q61159147 | ||
| Daniela Loessner | Q38544906 | ||
| P2093 | author name string | Feng Yang | |
| Ping Wang | |||
| Julia Dorn | |||
| Manfred Schmitt | |||
| Viktor Magdolen | |||
| Enken Drecoll | |||
| Matthias Kotzsch | |||
| Judith Ann Clements | |||
| Anja Rockstroh | |||
| P2860 | cites work | A novel role for BRCA1 in regulating breast cancer cell spreading and motility | Q24338824 |
| ERM proteins in cancer progression | Q26859107 | ||
| Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment | Q27335274 | ||
| The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer | Q74419518 | ||
| Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer | Q87351053 | ||
| Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. | Q40288565 | ||
| The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target. | Q41462285 | ||
| Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines | Q41607935 | ||
| CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. | Q41882383 | ||
| Differential cellular responses induced by dorsomorphin and LDN-193189 in chemotherapy-sensitive and chemotherapy-resistant human epithelial ovarian cancer cells. | Q46837899 | ||
| MAP4K4 regulates integrin-FERM binding to control endothelial cell motility | Q46917529 | ||
| Identification of keratin 19-positive cancer stem cells associating human hepatocellular carcinoma using CYFRA 21-1. | Q47151920 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy | Q47660938 | ||
| Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases. | Q48262377 | ||
| Serum cytokeratin-19 fragment (Cyfra 21-1) is a prognostic indicator for epithelial ovarian cancer | Q48306357 | ||
| Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients | Q48566969 | ||
| Whole-genome characterization of chemoresistant ovarian cancer | Q50272478 | ||
| Elevated Expression of Moesin in Muscular Dystrophies. | Q51194597 | ||
| Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage | Q58326895 | ||
| Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
| A role for AP-1 in apoptosis: the case for and against | Q28213346 | ||
| The emerging roles of human tissue kallikreins in cancer | Q28290701 | ||
| Parallel overexpression of seven kallikrein genes in ovarian cancer. | Q30923845 | ||
| MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin | Q33703121 | ||
| Prognostic value of the human kallikrein gene 15 expression in ovarian cancer | Q34221983 | ||
| Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma | Q34591070 | ||
| Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment | Q34602948 | ||
| Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. | Q34668770 | ||
| Kallikreins, steroid hormones and ovarian cancer: is there a link? | Q34714785 | ||
| The human keratins: biology and pathology | Q34776574 | ||
| A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread | Q34798735 | ||
| Trends in relative survival for ovarian cancer from 1975 to 2011. | Q35792998 | ||
| Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma. | Q36021623 | ||
| Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion | Q36171317 | ||
| Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome | Q36595049 | ||
| Regulation and function of JunB in cell proliferation | Q37269491 | ||
| Metastasis of ovarian cancer is mediated by kallikrein related peptidases | Q37480184 | ||
| The human kallikrein gene family: new biomarkers for ovarian cancer | Q37599420 | ||
| Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling | Q37730632 | ||
| Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers | Q38184632 | ||
| Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer | Q38188878 | ||
| Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer | Q38372729 | ||
| The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells. | Q38789245 | ||
| Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors | Q38835080 | ||
| Moesin regulates the motility of oral cancer cells via MT1-MMP and E-cadherin/p120-catenin adhesion complex | Q38851045 | ||
| Immunoregulation by members of the TGFβ superfamily | Q39019244 | ||
| Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells | Q39080408 | ||
| Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance | Q39281993 | ||
| Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma | Q39723990 | ||
| JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression | Q39922891 | ||
| Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells | Q40262739 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2018-10-05 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer | |
| P478 | volume | 119 |
| Q64097461 | Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients |
| Q97539581 | High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients |
| Q90403252 | Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line |
| Q91894566 | Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer |
Search more.